|
|
|
Insider
Information: |
Hooks Corwin Dale |
Relationship: |
|
City: |
Boulder |
State: |
CO |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
305,349 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$80 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
305,349 |
|
|
Total
Value |
$80 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Clovis Oncology, Inc. |
CLVS |
See Remarks |
2018-09-05 |
5,349 |
|
0 |
Premium* |
|
Applied Therapeutics Inc. |
APLT |
|
2024-04-12 |
300,000 |
2024-04-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CLVS |
Clovis Oncology, Inc. |
See remarksOfficer |
|
2016-02-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
703 |
|
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-06-06 |
4 |
D |
$47.70 |
$11,210 |
D/D |
(235) |
4,684 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-09-05 |
4 |
D |
$35.75 |
$8,544 |
D/D |
(239) |
5,349 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2017-11-29 |
4 |
D |
$59.49 |
$19,691 |
D/D |
(331) |
2,687 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-08-27 |
4 |
D |
$35.15 |
$15,255 |
D/D |
(434) |
5,119 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-05-31 |
4 |
D |
$48.63 |
$21,592 |
D/D |
(444) |
4,451 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-03-01 |
4 |
D |
$55.51 |
$25,923 |
D/D |
(467) |
3,089 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-06-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
468 |
4,919 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-09-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
469 |
5,588 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2017-11-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
868 |
3,018 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
869 |
3,556 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
869 |
3,958 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-08-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
869 |
5,553 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-03-07 |
4 |
D |
$58.43 |
$54,807 |
D/D |
(938) |
4,026 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-06-15 |
4 |
S |
$45.47 |
$42,696 |
D/D |
(939) |
1,595 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2017-08-25 |
4 |
D |
$73.16 |
$95,547 |
D/D |
(1,306) |
2,169 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2017-08-29 |
4/A |
D |
$72.14 |
$95,586 |
D/D |
(1,325) |
2,150 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-03-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,875 |
4,964 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2017-08-31 |
4 |
S |
$76.36 |
$164,174 |
D/D |
(2,150) |
19 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2017-08-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,475 |
3,475 |
0 |
- |
|
APLT |
Applied Therapeutics Inc. |
Chief Commercial Officer |
|
2024-04-12 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
300,000 |
0 |
- |
|
21 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|